Friday, 23 Mar 2018

You are here

22 September 2017 The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from This week's report discusses survey results on membranous nephritis and patient perceptions of steroids, nonadherence, celebrity arthritis and IgG4 treatment. 

  1. Framingham foot study- those with B/L foot pain have increased odds of knee & hip pain (males and females); ipsilateral foot & hip pain more in men
  2. Survey of glucocorticoid users: "steroids help alot" wherein the benefits outweigh adverse events. Yet AEs more common with GC use -thin skin, bruising, poor sleep, altered mood & moon face
  3. Astounding! Drug nonadherence is as high as 74% in AS, 90% in gout, 50% in PsA, 75% in SLE, 82% in RA 
  4. Statin use not assoc. w/ lupus in adults >40yrs; >1 yr of statin use has a 38% lower risk of developing SLE
  5. Retrospective review of 464 Polyarticular vs 42 Monarticular Septic arthritis: Many outcomes similar but Polyarticular septic Arthritis were more likely to have preexisting RA, higher SF WBC, longer hospital stays
  6. Survey of pediatric Rheums vs nephrologists showed nephrologists use less steroids (60% vs 93%) & MMF (53 vs 87%) than Rheums for management of membranous lupus nephritis without nephrotic syndrome.
  7. RA patients with fibromyalgia (17%) were unlikely to achieve SDAI remission, more pain/comorbidity, worse sleep, higher SF36 MCS  
  8. 50 pt trial of steroid injections vs wrist splinting for carpal tunnel syndrome shows injections with better dexterity, and patient satisfaction
  9. Selena Gomez recovering from renal transplant due to her Lupus.
  10. Lady Gaga has Fibromyalgia. She intends to shine the light on FM in a Netflix documentary "Lady Gaga:Five Foot Two"
  11. Mortality with Interstitial Lung Disease in Rheumatoid Arthritis.
  12. Romosuzumab Followed by Alendronate is Best in Fracture Prevention
  13. Rituximab Efficacy in IgG4 Related Disease
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

The RheumNow Week in Review - 23 March 2018

Dr. Jack Cush reviews the highlights from the news, journals and major meetings. New announcements and approval from the FDA; novel associations between ANCA vasculitis and thyroid disease; flare rates after arthroplasty; and pregnancy outcomes for men and women.

MMWR: Arthritis Prevalence Increases and Varies Widely

MMWR reports that In 2015, the number of adults with arthritis continued to increase; with marked geographic variability in arthritis estimates with gaps in arthritis management.

The CDC estimates that physician-diagnosed arthritis affects 54 million of adults in the United States with an annual cost of approximately $300 billion annually.

The RheumNow Week in Review - 16 March 2018

Dr. Jack Cush reviews the highlights from the news, journals and major meetings. Bigtime rheumatologic lessons with tales from intestinal crypts, the friendly skies & the hips of hockey players. Also the microbiome and lupus, benefits of ENT findings with GPA and rare risk of opportunistic infections with biologics.

The RheumNow Week in Review - 9 March 2018

Dr. Jack Cush reviews highlights, news and recent research published this past week on This week's report includes news on new regulatory changes, new indication for tofacitinib, the rise and deficits of opioids and the benefits of fish and bariatric surgery.

ACR Responds to Association Health Plans Proposed Rule

In comments submitted today to the US Department of Labor in response to its Association Health Plans (AHP) proposed rule, the American College of Rheumatology urged Administration officials to protect essential health benefits and other consumer protections that make it possible for individuals living with rheumatic diseases to access comprehensive and affordable healthcare.